Key result
Acute ischemic stroke is linked to ~39% higher early plasma F2-isoprostanes versus controls.
Case-Control (n=79)
BACKGROUND AND PURPOSE: Experimental stroke studies indicate that oxidative stress is a major contributing factor to ischemic cerebral injury. Oxidative stress is also implicated in activation of matrix metalloproteinases (MMPs) and blood-brain barrier injury after ischemia-reperfusion. Plasma biomarkers of oxidative stress may have utility as early indicators of efficacy in Phase 2 trials of antioxidant therapies in human stroke. To date, a valid biomarker has been unavailable. We measured F2-isoprostanes (F2IPs), free-radical induced products of neuronal arachadonic acid peroxidation, in acute ischemic stroke. We aimed to determine the change in plasma F2IP levels over time and relationship with plasma MMP-9 in tPA-treated and tPA-untreated stroke patients. METHODS: We performed a case-control study of consecutive ischemic stroke patients (25 tPA-treated and 27 tPA-untreated) presenting within 8 hours of stroke onset. Controls were individuals without prior stroke from a primary care clinic network serving the source population from which cases were derived. Infarct volume was determined on acute diffusion-weighted MRI (DWI) performed within 48 hours using a semi-automated computerized segmentation algorithm. Phlebotomy was performed at <8 hours, 24 hours, 2 to 5 days, and 4 to 6 weeks. F2IPs were measured by gas chromatography/mass spectrometry and MMP-9 by ELISA. Prestroke antioxidant dietary intake was measured by the 24-hour recall method. RESULTS: In 52 cases and 27 controls, early (median 6 hours postonset) F2IPs were elevated in stroke cases compared with controls (medians 0. 041 versus 0.0295 pg/mL, P=0.012). No difference in F2IPSs was present at later time points. Early plasma F2IPs correlated with MMP-9 in all patients (P=0.01) and the tPA-treated subgroup (P=0.02). No correlation was found with NIHSS, DWI infarct volume, 90-day Rankin score, or C-reactive protein (P>0.05 for all). CONCLUSIONS: In early human stroke we found evidence of increased oxidative stress and a relationship with MMP-9 expression, supporting findings from experimental studies.
No takes yet. Share an insight, caveat, or question.
Kelly et al. (2007) conducted a case-control in Acute ischemic stroke (n=79). Acute ischemic stroke (and tPA treatment) vs. Individuals without prior stroke from a primary care clinic network was evaluated on Early (median 6 hours postonset) plasma F2-isoprostane (F2IP) levels (pg/mL) and correlation with plasma MMP-9 (p=0.012). Acute ischemic stroke was associated with higher early plasma F2-isoprostanes versus controls (median 0.041 vs 0.0295 pg/mL, P=0.012), which correlated with MMP-9 levels (P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: